Puk19 - Cost-Utility of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients Undergoing Dialysis in Canada

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2817
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hyperphosphatemia in Chronic Kidney Disease

Medical Council
2019English

Hyperphosphatemia in Chronic Kidney Disease: Patient Characteristics and Dialysis Mortality During the First Year of Dialysis

Journal of Nephrology & Therapeutics
2012English

The Management of Hyperphosphatemia by Lanthanum Carbonate in Chronic Kidney Disease Patients

International Journal of Nephrology and Renovascular Disease
Nephrology
2012English

Monitoring of the Cost of Medicines Used for Peritoneal Dialysis in Patients With Chronic Kidney Disease

Socìalʹna farmacìâ v ohoronì zdorov'â
2015English

Modification of Laparoscopic Catheter Setting for Peritoneal Dialysis in Patients With Chronic Kidney Disease

Reports of Vinnytsia National Medical University
2019English

A Study of Lipid Profile in Chronic Kidney Disease in Pre- Dialysis Patients

International Journal of Medical Research and Review
2019English

New Oral Direct-Acting Antiviral Agents for Treatment of Chronic Hepatitis-C Infection in Patients With Chronic Kidney Disease Including Dialysis Patients and Kidney Transplant Recipients

SM Journal of Nephrology and Therapeutics
2017English

Lipid Profile in Pre-Dialysis Chronic Kidney Disease Patients in Southern Nigeria

Ghana Medical Journal
Medicine
2016English

Xerostomia as a Contributing Factor for Taste Distortion in Patients Undergoing Chronic Dialysis Treatment

American Research Journal of Dentistry
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy